Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,751 | 604 | 56.2% |
| Consulting Fee | $5,875 | 1 | 42.6% |
| Education | $173.85 | 12 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $5,891 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $805.48 | 46 | $0 (2020) |
| Amgen Inc. | $640.11 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $639.10 | 80 | $0 (2020) |
| PFIZER INC. | $576.24 | 70 | $0 (2024) |
| AbbVie Inc. | $545.07 | 30 | $0 (2020) |
| Novo Nordisk Inc | $514.93 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $461.99 | 58 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $449.17 | 33 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $377.33 | 26 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,088 | 11 | ACADIA Pharmaceuticals Inc ($5,875) |
| 2020 | $326.02 | 20 | Janssen Pharmaceuticals, Inc ($85.53) |
| 2019 | $1,549 | 111 | AstraZeneca Pharmaceuticals LP ($179.90) |
| 2018 | $2,813 | 225 | Amgen Inc. ($289.50) |
| 2017 | $3,025 | 250 | AstraZeneca Pharmaceuticals LP ($384.18) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Neuromodulation | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $20.15 | General |
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Gastroenterology | ||||||
| 08/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Obesity | ||||||
| 06/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $5,875.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/12/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/11/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Obesity | ||||||
| 03/09/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | COMBIVENT RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular | ||||||
| 03/05/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/02/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: KRYSTEXXA | ||||||
| 03/01/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/24/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Bone Health | ||||||
| 02/18/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 01/31/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/30/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,047 | 1,820 | $306,357 | $98,792 |
| 2022 | 19 | 1,152 | 1,874 | $292,719 | $81,322 |
| 2021 | 22 | 3,377 | 4,300 | $494,605 | $158,611 |
| 2020 | 22 | 1,494 | 2,180 | $281,887 | $66,932 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 340 | 740 | $178,340 | $50,823 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 275 | $45,650 | $14,619 | 32.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 104 | 106 | $10,070 | $7,938 | 78.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 35 | 79 | $17,416 | $5,912 | 33.9% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 45 | 46 | $14,030 | $4,673 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 121 | 123 | $7,872 | $3,604 | 45.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 45 | $9,000 | $2,548 | 28.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 24 | 42 | $7,476 | $2,378 | 31.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 37 | 82 | $4,182 | $2,006 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,584 | $1,308 | 36.5% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $3,326 | $995.20 | 29.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 77 | $2,464 | $780.48 | 31.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 20 | 28 | $868.00 | $374.58 | 43.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 38 | $950.00 | $361.76 | 38.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 14 | 14 | $532.00 | $306.60 | 57.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 26 | $390.00 | $88.66 | 22.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 69 | $207.00 | $75.56 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 539 | $129,899 | $25,822 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 252 | 466 | $77,356 | $19,550 | 25.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 35 | 119 | $23,800 | $8,098 | 34.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 107 | 107 | $10,165 | $7,439 | 73.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 133 | 135 | $8,640 | $3,781 | 43.8% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 28 | 30 | $8,430 | $2,943 | 34.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 52 | 81 | $4,131 | $2,849 | 69.0% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 12 | 25 | $7,325 | $2,529 | 34.5% |
About Dr. Richard Kimani, M.D
Dr. Richard Kimani, M.D is a Internal Medicine healthcare provider based in Mcminnville, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417951849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Kimani, M.D has received a total of $13,800 in payments from pharmaceutical and medical device companies, with $6,088 received in 2024. These payments were reported across 617 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,751).
As a Medicare-enrolled provider, Kimani has provided services to 7,070 Medicare beneficiaries, totaling 10,174 services with total Medicare billing of $405,657. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mcminnville, OR
- Active Since 06/13/2005
- Last Updated 01/02/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417951849
Products in Payments
- NUPLAZID (Drug) $5,891
- SYMBICORT (Drug) $522.11
- XARELTO (Drug) $458.13
- Prolia (Biological) $346.00
- Creon (Drug) $335.62
- JANUVIA (Drug) $326.19
- ELIQUIS (Drug) $323.59
- CHANTIX (Drug) $258.41
- Victoza (Drug) $232.35
- JARDIANCE (Drug) $221.26
- TRULICITY (Drug) $180.92
- INVOKANA (Drug) $174.95
- TOUJEO (Drug) $171.72
- XIFAXAN (Drug) $171.70
- TRADJENTA (Drug) $170.22
- ENTRESTO (Drug) $166.30
- BREO (Drug) $162.31
- Mavyret (Drug) $154.87
- RELISTOR (Drug) $145.59
- ANORO (Drug) $141.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mcminnville
Kishore Pathial, Md, MD
Internal Medicine — Payments: $8,661
Cetin Hekimoglu, Md, MD
Internal Medicine — Payments: $2,239
Krystal Samuel, Do, DO
Internal Medicine — Payments: $816.07
Dr. Everald Walker, Md, MD
Internal Medicine — Payments: $720.72
Keith Webb, Md, MD
Internal Medicine — Payments: $703.83
Sonja Webb, M.d, M.D
Internal Medicine — Payments: $625.13